Egnyte Launches GxP-Compliant Data Governance Tools for Life Sciences
Event summary
- Egnyte introduced next-generation data governance solutions for life sciences at SCOPE 2026, including a GxP-validated eSignature solution compliant with 21 CFR Part 11.
- Enhanced Controlled Documents feature configurable categories and document statuses to streamline compliance workflows.
- Egnyte will present on Quality by Design for data governance at SCOPE 2026 on February 4, 2026.
- The company will showcase its capabilities at booth #228 in Orlando from February 2 to 5, 2026.
The big picture
Egnyte’s latest offerings address the growing need for secure, compliant data management in life sciences, where regulatory scrutiny and clinical trial complexities demand robust governance solutions. The move aligns with broader industry trends toward digital transformation and AI-driven compliance automation, positioning Egnyte to capture market share in a sector increasingly prioritizing data integrity.
What we're watching
- Adoption Pace
- How quickly life sciences firms will integrate Egnyte’s GxP-compliant tools into existing workflows.
- Regulatory Impact
- Whether the enhanced compliance features will reduce audit risks and accelerate clinical timelines.
- Market Differentiation
- The extent to which Egnyte’s specialized solutions can outpace competitors in the life sciences data governance space.
Related topics